Tianjin Tianyao Pharmaceuticals Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is CELECOXIB USP, with a corresponding US DMF Number 27635.
Remarkably, this DMF maintains an Active status since its submission on March 24, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 08, 2015, and payment made on May 12, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II